Blistex Deep Renewal Broad Spectrum (Blistex Inc)


Welcome to the PulseAid listing for the Blistex Deep Renewal Broad Spectrum drug offered from Blistex Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Blistex Inc
NON-PROPRIETARY NAME: DIMETHICONE, AVOBENZONE, OCTINOXATE, and OCTISALATE
SUBSTANCE NAME: DIMETHICONE; AVOBENZONE; OCTINOXATE; OCTISALATE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: STICK
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2016-05-01
END MARKETING DATE: 0000-00-00


Blistex Deep Renewal Broad Spectrum HUMAN OTC DRUG Details:

Item DescriptionBlistex Deep Renewal Broad Spectrum from Blistex Inc
LABELER NAME: Blistex Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 2; 3; 6.6; 4.4(g/100g; g/100g; g/100g; g/100g)
START MARKETING DATE: 2016-05-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10157-1108_e9351014-c85c-41c7-aad4-20a7e333d2da
PRODUCT NDC: 10157-1108
APPLICATION NUMBER: part347

Other DIMETHICONE; AVOBENZONE; OCTINOXATE; OCTISALATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Blistex IncBlistex Deep Renewal Broad Spectrum